Granzyme B levels are elevated in the CSF of MS patients (42) and CD4+ T cells from MS patients secrete more granzyme B than healthy controls in the relapsing–remitting (85) and progressive forms (86). This evidence concerns the gene GZMB and myeloid sarcoma.